2.23.12
this week's post
|
post archives
|
Social Media Center
|
Case Studies
|
about
|
contact
FDA
Leave a Reply
Name (required)
Mail (will not be published) (required)
Website
Subscribe to our feed
by e-mail
Subscribe to our
RSS Feed
Follow Snapshot on
Twitter
Join our network on
Linked In
Friend us on
Facebook
Industry Blogs
Chicago Tribune Inside Health Care
Eye on FDA
Fierce Biotech
Fierce Vaccines
NPR Health Blog
Pharma Marketing Blog
Pharma Strategy Blog
Pharmaceutical Executive Magazine Blog
The IN VIVO Blog
Wall Street Journal Health Blog
RSHC Twitter Feed
RT
@wsj
: Breaking: An FDA advisory panel overwhelmingly backed Vivus Inc.s weight loss drug Qnexa.
http://t.co/Ll51SoDB
about 9 hours ago
from
HootSuite
Reply
Retweet
Favorite
Today's News:Weldon's legacy,India may fix drug prices,NICE ok's
#Roche
drug post-price cut,Livestock &
#super
bugshttp://ow.ly/9dwG5
#hcpr
about 18 hours ago
from
HootSuite
Reply
Retweet
Favorite
Ouch. ALWAYS check twice before publishing...Jeremy Lin headline slur was ‘honest mistake,’ fired ESPN editor Anthony Federico...
04:13:45 PM February 21, 2012
from
HootSuite
Reply
Retweet
Favorite
What is
#medical
value? Safety, efficacy and medical need are no longer enough.
http://t.co/o7M90hBa
#hcpr
#healthcare
PR
03:25:05 PM February 21, 2012
from
HootSuite
Reply
Retweet
Favorite
RT
@societyxfactor
: Love the headline for $THLD....63% improvement in PFS....true, but what if the headline just said, a 2 month...
01:18:08 PM February 21, 2012
from
HootSuite
Reply
Retweet
Favorite
@Betsy_RSHC
Search
RSHC copyright © 2009